Surgical Science Sweden AB (publ) (STO:SUS)
31.44
-0.60 (-1.87%)
At close: Mar 9, 2026
STO:SUS Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 66.82 | 131.65 | 233.97 | 187.97 | 86.25 | Upgrade
|
| Depreciation & Amortization | 83.37 | 41.36 | 38.4 | 35.66 | 23.9 | Upgrade
|
| Other Amortization | - | 19.15 | 17.21 | 15.93 | 9.62 | Upgrade
|
| Other Operating Activities | -8.7 | 10.95 | -45.64 | -44.46 | -34 | Upgrade
|
| Change in Accounts Receivable | -87.61 | -20.24 | 31.91 | -70.76 | -84.57 | Upgrade
|
| Change in Inventory | -16.39 | -11.56 | -19.57 | -21.72 | 6.46 | Upgrade
|
| Change in Other Net Operating Assets | 42.31 | -34.09 | -17.99 | 26.87 | 31.43 | Upgrade
|
| Operating Cash Flow | 79.8 | 137.23 | 238.29 | 129.49 | 39.08 | Upgrade
|
| Operating Cash Flow Growth | -41.85% | -42.41% | 84.03% | 231.31% | 68.28% | Upgrade
|
| Capital Expenditures | -11.68 | -6.1 | -10.46 | -9.35 | -3.87 | Upgrade
|
| Cash Acquisitions | -84.91 | - | - | - | -2,718 | Upgrade
|
| Sale (Purchase) of Intangibles | -37.66 | -41.43 | -33.67 | -25.2 | -10.51 | Upgrade
|
| Other Investing Activities | 0 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -134.25 | -47.53 | -44.13 | -34.55 | -2,733 | Upgrade
|
| Long-Term Debt Issued | - | 235.41 | - | 17.09 | - | Upgrade
|
| Long-Term Debt Repaid | -259.72 | -2.23 | -1.26 | - | -31.72 | Upgrade
|
| Total Debt Repaid | -259.72 | -2.23 | -1.26 | - | -31.72 | Upgrade
|
| Net Debt Issued (Repaid) | -259.72 | 233.18 | -1.26 | 17.09 | -31.72 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 3,039 | Upgrade
|
| Other Financing Activities | 0.05 | -5.53 | 17.11 | - | -84.87 | Upgrade
|
| Financing Cash Flow | -259.68 | 227.65 | 15.85 | 17.09 | 2,922 | Upgrade
|
| Foreign Exchange Rate Adjustments | -37.6 | 16.44 | -9.38 | 5.02 | 0.59 | Upgrade
|
| Net Cash Flow | -351.73 | 333.79 | 200.63 | 117.05 | 229.52 | Upgrade
|
| Free Cash Flow | 68.12 | 131.12 | 227.84 | 120.14 | 35.21 | Upgrade
|
| Free Cash Flow Growth | -48.05% | -42.45% | 89.65% | 241.18% | 54.26% | Upgrade
|
| Free Cash Flow Margin | 6.86% | 14.83% | 25.81% | 14.97% | 9.60% | Upgrade
|
| Free Cash Flow Per Share | 1.33 | 2.57 | 4.47 | 2.36 | 0.82 | Upgrade
|
| Cash Income Tax Paid | 49.5 | 27.69 | 14.55 | 8.48 | 3.43 | Upgrade
|
| Levered Free Cash Flow | -217.78 | 279.47 | 94.14 | 95.86 | 17.79 | Upgrade
|
| Unlevered Free Cash Flow | -213.91 | 279.94 | 94.55 | 96.19 | 18.11 | Upgrade
|
| Change in Working Capital | -61.7 | -65.89 | -5.65 | -65.61 | -46.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.